Results 271 to 280 of about 7,978,447 (307)
Some of the next articles are maybe not open access.
Major Adverse Cardiovascular Events in Bulgarian Patients with Chronic Coronary Syndrome
Nigerian Journal of Clinical Practice, 2022Background: In primary prevention, most guidelines rely on atherosclerotic cardiovascular disease risk assessment to determine the appropriateness and intensity of risk factor modification. Aims: This study aimed to analyze the prognostic role of risk factors, comorbidities, and ...
B, Stoimenov +5 more
openaire +2 more sources
Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients
Expert Review of Cardiovascular Therapy, 2019Introduction: The GLP-1 receptor agonist (GLP-1 RA) liraglutide has a half-life of approximately 13 h and is suitable for subcutaneous administration once daily. The use of liraglutide in people with type 2 diabetes has become popular because of the efficacy and durability in relation to glycemic control in combination with weight loss in most patients.
openaire +3 more sources
The association between thoracic periaortic fat and major adverse cardiovascular events
Wiener klinische Wochenschrift, 2015The study aimed to examine the association between thoracic periaortic fat tissue volume and the long-term incidence of major adverse cardiovascular events.This retrospective cohort study included 433 consecutive patients (372 male and 61 female). Periaortic fat tissue volume was measured via electrocardiogram-gated 64-multidetector computed tomography.
Zeynettin, Kaya +8 more
openaire +2 more sources
Association Between Fluoroquinolones and Major Adverse Cardiovascular Events: A Systematic Review
Cardiology in ReviewFluoroquinolones (FQs) are routinely administered antibiotics that have demonstrated an increased propensity to cause major adverse cardiovascular events (MACE). We conducted a systematic review aimed to investigate the association between FQ usage and the risk of MACE.
Hritvik, Jain +11 more
openaire +2 more sources
Copeptin associates with major adverse cardiovascular events in patients on maintenance hemodialysis
Clinica Chimica ActaEnd-stage renal disease (ESRD) necessitating hemodialysis pose substantial cardiovascular risks, with cardiovascular disease (CVD) as a leading cause of mortality. Biomarkers like copeptin have emerged as potential indicators of cardiovascular stress and prognosis in CKD populations.This study aimed to assess the prognostic value of copeptin in ...
Zhen Zhang +9 more
openaire +2 more sources
Echocardiography Predicts Major Adverse Cardiovascular Events after Renal Transplantation
Nephron Clinical Practice, 2014<b><i>Introduction:</i></b> Cardiovascular disease is a leading cause of morbidity and mortality after renal transplantation. We analysed whether pre-transplant transthoracic echocardiograms (TTE) predicted major adverse cardiovascular events (MACE) after transplant.
Gu, Haotian +5 more
openaire +3 more sources
Major Adverse Cardiovascular Events and Prognosis in Patients With Coronary Slow Flow
Current Problems in CardiologyThis study aimed to investigate its clinical implications, risk factors, prognosis, and overall long-term outcomes. Demographic profiles, various clinical characteristics, and clinical outcomes were compared between 614 patients with coronary slow flow (CSF) and 428 patients with normal coronary artery.
Jiang Yu +7 more
openaire +2 more sources
Sex-Specific Trajectories of Arterial Stiffness and Major Adverse Cardiovascular Events
HypertensionBACKGROUND: Sex-specific associations between brachial-ankle pulse wave velocity (baPWV) and major adverse cardiovascular events (MACE) remain unclear. Evidence for cardiovascular effects of longitudinal baPWV change is particularly lacking. METHODS:
Wanyue Wang +9 more
openaire +2 more sources